Health

First leukaemia patient to receive pioneering treatment on NHS says it is 'very sci-fi'

January 14, 2026

Oscar Murphy, the first leukaemia patient to receive CAR-T therapy on the NHS, describes the experience as 'fantastic' and 'very sci-fi.' The 28-year-old underwent this groundbreaking treatment at Manchester Royal Infirmary, which involves genetically modifying his immune cells to attack cancer. NHS England plans to fund this innovative immunotherapy at multiple centers, potentially benefiting around 50 patients annually.

A man with brown hair and a beard smiling wearing aviator-style glasses sits in a hospital bed. He is wearing a red Lilo and Stitch top

Credit: Co

Key Highlights

Oscar Murphy is the first leukaemia patient to receive CAR-T therapy on the NHS.
The treatment took place at Manchester Royal Infirmary.
CAR-T therapy involves genetically modifying the patient's immune cells.
NHS England will fund the treatment at several centers across the UK.
Approximately 50 NHS patients per year are expected to benefit from this therapy.

Sources

First leukaemia patient to receive pioneering treatment on NHS says it is 'very sci-fi'

This quick summary is automatically generated using AI based on reports from multiple news sources. The content has not been reviewed or verified by humans. For complete details, accuracy, and context, please refer to the original published articles.

First leukaemia patient to receive pioneering treatment on NHS says it is 'very sci-fi'

Key Highlights

Sources

Related Stories

Dark, Velvety Patches on Skin May Signal Insulin Resistance, Early Diabetes Risk

One in four UK teenagers in care have attempted to end their lives, study says

Five minutes more exercise and 30 minutes less sitting could help millions live longer